8k filedTOVXsec-api
Theriva Biologics, Inc. (TOVX) Reports Material Event to SEC
Theriva Biologics, Inc. (AMEX:TOVX) filed a Form 8-K with the Securities and Exchange Commission on August 11, 2026, disclosing a material event.
Read moreFeatured By
Real-time context
Material company disclosures filed with the SEC.
Theriva Biologics, Inc. (AMEX:TOVX) filed a Form 8-K with the Securities and Exchange Commission on August 11, 2026, disclosing a material event.
Read moreC4 Therapeutics, Inc. (NASDAQ:CCCC) filed its quarterly report (Form 10-Q) with the Securities and Exchange Commission on August 11, 2026.
Read moreEnviri Corp (NYSE:NVRI) filed a Form 8-K with the Securities and Exchange Commission on August 11, 2026, disclosing a material event.
Read moreSagimet Biosciences Inc. (NASDAQ:SGMT) filed its quarterly report (Form 10-Q) with the Securities and Exchange Commission on August 11, 2026.
Read moreTON Strategy Co (NASDAQ:TONX) filed a Form 8-K with the Securities and Exchange Commission on August 11, 2026, disclosing a material event.
Read moreZura Bio Ltd (NASDAQ:ZURA) filed its quarterly report (Form 10-Q) with the Securities and Exchange Commission on August 11, 2026.
Read moreVeradermics, Inc (NYSE:MANE) filed a Form 8-K with the Securities and Exchange Commission on August 11, 2026, disclosing a material event.
Read moreTheravance Biopharma, Inc. (NASDAQ:TBPH) filed its quarterly report (Form 10-Q) with the Securities and Exchange Commission on August 11, 2026.
Read moreMereo BioPharma Group plc (NASDAQ:MREO) filed a Form 8-K with the Securities and Exchange Commission on August 11, 2026, disclosing a material event.
Read moreSMITHFIELD FOODS INC (NASDAQ:SFD) filed its quarterly report (Form 10-Q) with the Securities and Exchange Commission on August 11, 2026.
Read moreENERGY FOCUS, INC/DE (NASDAQ:EFOI) filed a Form 8-K with the Securities and Exchange Commission on August 11, 2026, disclosing a material event.
Read morePrelude Therapeutics Inc (NASDAQ:PRLD) filed its quarterly report (Form 10-Q) with the Securities and Exchange Commission on August 11, 2026.
Read moreWEC ENERGY GROUP, INC. (NYSE:WEC) filed a Form 8-K with the Securities and Exchange Commission on August 11, 2026, disclosing a material event.
Read moreCoya Therapeutics, Inc. (NASDAQ:COYA) filed its quarterly report (Form 10-Q) with the Securities and Exchange Commission on August 11, 2026.
Read moreUltragenyx Pharmaceutical Inc. (NASDAQ:RARE) filed a Form 8-K with the Securities and Exchange Commission on August 11, 2026, disclosing a material event.
Read moreLB PHARMACEUTICALS INC (NASDAQ:LBRX) filed its quarterly report (Form 10-Q) with the Securities and Exchange Commission on August 11, 2026.
Read morePDS Biotechnology Corp (NASDAQ:PDSB) filed a Form 8-K with the Securities and Exchange Commission on August 11, 2026, disclosing a material event.
Read moreProtara Therapeutics, Inc. (NASDAQ:TARA) filed its quarterly report (Form 10-Q) with the Securities and Exchange Commission on August 11, 2026.
Read moreAdagio Medical Holdings, Inc. (NASDAQ:ADGM) filed a Form 8-K with the Securities and Exchange Commission on August 11, 2026, disclosing a material event.
Read moreMAGELLAN COPPER & GOLD Corp (OTC:MAGE) filed its quarterly report (Form 10-Q) with the Securities and Exchange Commission on August 11, 2026.
Read more